Literature DB >> 3332892

Amphotericin B dosage for disseminated candidiasis in premature infants.

J E Hall1, F Cox, K Karlson, A Robertson.   

Abstract

Amphotericin B (Amp-B) serum concentrations were determined in five infants with disseminated candidiasis. All patients had positive blood cultures for Candida and one patient had Candida albicans meningitis. Amp-B sterilized the blood and the cerebrospinal fluid within four to nine days. Total doses of Amp-B varied from 11.6-62.3 mg. There was no laboratory or clinical evidence of renal toxicity. Two infants died of causes unrelated to disseminated candidiasis. Disseminated candidiasis in premature infants was treated successfully with 0.5 mg/kg doses of Amp-B, but further studies with more evaluable cases are needed to confirm the correct dose.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3332892

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  3 in total

1.  Pharmacokinetics of amphotericin B in children.

Authors:  J M Benson; M C Nahata
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

Review 2.  Antifungals in systemic neonatal candidiasis.

Authors:  Daniel A C Frattarelli; Michael D Reed; George P Giacoia; Jacob V Aranda
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 3.  Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.

Authors:  Jessica K Roberts; Chris Stockmann; Jonathan E Constance; Justin Stiers; Michael G Spigarelli; Robert M Ward; Catherine M T Sherwin
Journal:  Clin Pharmacokinet       Date:  2014-07       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.